Clinical trial
Phase II Randomised Study of Nasal Oxygen Treatment for Pain Relief During Percutaneous Coronary Interventions
NCT01413841 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Randomised Study of Nasal Oxygen Treatment for Pain Relief During Percutaneous Coronary Interventions
- Lead sponsor
- Region Skane
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- June 30, 2012
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angina